[Combined therapy with tricyclic and MAOI antidepressants in the treatment of resistant major depression].
This paper shows the results of associating tricyclic and MAOI antidepressants in the treatment of resistant major depression. Forty five patients from private practice with diagnosis of major depression according to DSM III R criteria, with negative response to separate tricyclic or MAOI treatment, were given both types associated. They improved without dangerous side effects.
D000328:Adult; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales
D000929:Antidepressive Agents, Tricyclic; D008996:Monoamine Oxidase Inhibitors
Tratamiento combinado de la depresión resistente con antidepresivos tricíclicos e inhibidores de la monoaminoxidasa.